Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
380 participants
OBSERVATIONAL
2024-07-01
2034-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Moreover, the specific goals are to generate an alert system for possible cases of RD with data from the electronic medical record, to describe the occurrence of RD in the evaluated population, to characterize the population, to describe patterns of diagnosis and treatment of RD present at the time, and to explore patient-reported outcomes.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Swiss Rare Disease Registry (SRDR)
NCT05179863
Hypoplastic Left Heart Syndrome: Subendocardial Viability After Norwood Palliation
NCT05709275
Study of Skeletal Disorders
NCT05031507
Biomarkers and Outcome Predictors of Pediatric Nephrotic Syndrome: A Genetic, Transcriptomic, and Secretome Multiomics Study
NCT06792448
Retrospective Multicentre Study on the Impact of Neonatal Screening for Congenital Adrenal Hyperplasia in Italy
NCT06728748
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The fragmentation of data on these diseases makes it difficult to understand them comprehensively. Therefore, the creation of a macro institutional registry that brings together information on RD would facilitate research in this field.
The registries are organized systems of systematic data collection of a large number of patients quickly and efficiently on a particular disease at a given time.
The main difficulty of the registries is the guarantee of the quality of their data.
The main objectives of the registry are:
Understand risk factors and prognosis. Evaluate the diagnostic and therapeutic comparison with current standards. Advance knowledge of the disease to optimize the assessment, treatment and monitoring of patients.
Analyze the effectiveness of new therapies. Studying differences between populations. Quickly estimate the morbidity, mortality and resource utilization associated with a disease entity.
Examine the course of a disease Formulate novel hypotheses for further prospective studies.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
OTHER
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Must be followed at Hospital Italiano de Buenos Aires.
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospital Italiano de Buenos Aires
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
MARIA LOURDES POSADAS MARTINEZ
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Marcelo Serra, PhD
Role: PRINCIPAL_INVESTIGATOR
HIBA
Soledad Kleppe, MD
Role: PRINCIPAL_INVESTIGATOR
HIBA
Maria Lourdes Posadas Martinez, PhD
Role: PRINCIPAL_INVESTIGATOR
HIBA
Luis Mazzuoccolo, MD
Role: STUDY_CHAIR
HIBA - dermatología
María Fabiana Russo Picasso, MD
Role: STUDY_CHAIR
HIBA - endocrinología
Eduardo Jorge Premoli, MD
Role: STUDY_CHAIR
HIBA - oftalmología
Mariano Martín Marcolongo, MD
Role: STUDY_CHAIR
HIBA - gastroenterología
Javier Pollan, MD
Role: STUDY_CHAIR
HIBA - clínica médica
Adrian Gadano, MD
Role: STUDY_CHAIR
HIBA - investigación
Pablo Lobos, MD
Role: STUDY_CHAIR
HIBA - cirugía pediátrica
Hernan Garcia Rivello, MD
Role: STUDY_CHAIR
HIBA - patología clínica
Marcelo Risk, PhD
Role: STUDY_CHAIR
IMTIB
Marcelo Rugiero, MD
Role: STUDY_CHAIR
HIBA - neurología
Julio Busaniche, MD
Role: STUDY_CHAIR
HIBA - clínica pediátrica
Rodolfo Pizarro, MD
Role: STUDY_CHAIR
HIBA - cardiología
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital Italiano de Buenos Aires
Buenos Aires, Buenos Aires, Argentina
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Griggs RC, Batshaw M, Dunkle M, Gopal-Srivastava R, Kaye E, Krischer J, Nguyen T, Paulus K, Merkel PA; Rare Diseases Clinical Research Network. Clinical research for rare disease: opportunities, challenges, and solutions. Mol Genet Metab. 2009 Jan;96(1):20-6. doi: 10.1016/j.ymgme.2008.10.003. Epub 2008 Nov 13.
Stoller JK. The Challenge of Rare Diseases. Chest. 2018 Jun;153(6):1309-1314. doi: 10.1016/j.chest.2017.12.018. Epub 2018 Jan 8.
Gliklich RE, Dreyer NA, Leavy MB, editors. Registries for Evaluating Patient Outcomes: A User's Guide [Internet]. 3rd edition. Rockville (MD): Agency for Healthcare Research and Quality (US); 2014 Apr. Report No.: 13(14)-EHC111. Available from http://www.ncbi.nlm.nih.gov/books/NBK208616/
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
12332
Identifier Type: REGISTRY
Identifier Source: secondary_id
7014
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.